发明名称 Rivastigmine for the treatment of ocular disorders
摘要 Use of a compound of formula (I) where: R1 is hydrogen, lower alkyl, cyclohexyl, allyl, or benzyl; R2 is hydrogen, methyl, ethyl, or propyl; or R1 and R2 together with the nitrogen to which they are attached form a morpholino or piperidino radical; R3 is hydrogen or lower alkyl; R4 and R5 are the same or different and each is a lower alkyl; and the dialkylaminoialkyl groups is in the meta, ortho, or para position. Compound of formula (I) may treatment glaucoma, normal tension glaucoma and neurodegenerative disease conditions of the retina and the optic nerve.
申请公布号 NZ518164(A) 申请公布日期 2003.10.31
申请号 NZ20000518164 申请日期 2000.10.17
申请人 NOVARTIS AG 发明人 GOLDBLUM, DAVID
分类号 A61K31/27;A61P27/06;(IPC1-7):A61K31/27 主分类号 A61K31/27
代理机构 代理人
主权项
地址